Atropos Health
atroposhealth.com
Actively hiring
Data & Analytics
Clinical Research
Health Care
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Overview
Atropos Health generates real world evidence from clinical data on demand. Its platform answers physician questions with rapid observational studies. The company spun out of Stanford medical informatics research.
News
Association Between Semaglutide and Risk of Bone Fractures in Type 2 Diabetes
A study titled "Association Between Semaglutide and Risk of Bone Fractures in Type 2 Diabetes" was presented at the Endocrine Society's ENDO 2026 Annual Meeting in Chicago by co-authors Jairo Noreña Velasquez, MD; William C. Pike, MD; Gavin Hui, MD; Yasam
Read more
Report
Atropos Health Expands Partnership with Databricks with the Launch of the Atropos Evidence Agent MCP on Databricks Marketplace
Atropos Health and Databricks have expanded their partnership, bringing the Atropos Evidence Agent MCP directly to the Databricks Marketplace. Clinicians, researchers, and life sciences teams can now use AI agents to ask questions and get evidence-backed
Read more
Report
Association Between Selective Serotonin Reuptake Inhibitor Use and Outcomes in Metastatic Melanoma Treated With Immune Checkpoint Inhibitors
A poster titled "Association Between Selective Serotonin Reuptake Inhibitor Use and Outcomes in Metastatic Melanoma Treated With Immune Checkpoint Inhibitors: A Real-World Cohort Study" was presented at the ASCO 2026 Annual Meeting by author Sandeep Kumar
Read more
Report
Using Machine Learning and Real-World Data to Identify Patients with Early Stage Bipolar-I Disorder for whom Aripiprazole Monohydrate LAIs are Likely to be a Favorable Treatment Option
A poster titled "Using Machine Learning and Real-World Data to Identify Patients with Early Stage Bipolar-I Disorder for whom Aripiprazole Monohydrate LAIs are Likely to be a Favorable Treatment Option" was presented at the American Society of Clinical Ps
Read more
Report
Using Machine Learning and Real-World Data to Identify Patients with Schizophrenia for whom Aripiprazole Monohydrate LAIs are Likely to be a Favorable Treatment Option
A poster titled "Using Machine Learning and Real-World Data to Identify Patients with Schizophrenia for whom Aripiprazole Monohydrate LAIs are Likely to be a Favorable Treatment Option" was presented at the American Society of Clinical Psychopharmacology
Read more
Report
Pro access
Upgrade to see all 20 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Growth
Hiring Momentum
48/100
Stable
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~1 hours
09/06/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
100% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Palo Alto
United States
HQ